✦ LIBER ✦

PDG12: CLINICAL BENEFITS AND COST-OFFSETS OF COMBINATION THERAPY WITH NATEGLINIDE PLUS METFORMIN VERSUS METFORMIN ALONE IN DIABETES IN THE NETHERLANDS

✍ Scribed by Boom G van den; MA Koopmanschap; J Caro; J Grueger

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparing the Long-term Cost-effectivene

✍ Palmer, Andrew J.; Roze, Stéphane; Lammert, Morten; Valentine, William J.; Minsh 📂 Article 📅 2004 🏛 Informa plc 🌐 English ⚖ 420 KB

PDB11 LONG-TERM COST-EFFECTIVENESS ANALY

✍ J Ray; AS Brandt; V Foos; V Munro; WJ Valentine; S Roze; AJ Palmer 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

Liraglutide + Metformin Combination Ther

✍ Bowering, Keith; Bain, Stephen C.; Seufert, Jochen; Thomsen, Anne B.; Furber, Sa 📂 Article 📅 2012 🏛 Canadian Diabetes Association 🌐 English ⚖ 49 KB

Efficacy and safety of combination thera

✍ Ji, Li-Nong; Pan, Chang-Yu; Lu, Ju-Ming; Li, Hong; Li, Qiang; Li, Qi-Fu; Peng, Y 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 232 KB

A randomized controlled trial of the eff

✍ White, Judith L; Buchanan, Patricia; Li, Jia; Frederich, Robert 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 383 KB

PDB50 Long-Term Clinical and Economic Be

✍ W.C. Lee; Y. Samyshkin; J. Langer; J.L. Palmer 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB